Stroke - international conference 2006

IDrugs. 2006 Apr;9(4):247-9.
No abstract available

Publication types

  • Congress

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors
  • 3',5'-Cyclic-AMP Phosphodiesterases / genetics
  • 5-Lipoxygenase-Activating Proteins
  • Benzenesulfonates / therapeutic use
  • Cardiovascular Agents / therapeutic use
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / genetics
  • Clinical Trials as Topic
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Humans
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / genetics
  • Nitrogen Oxides / therapeutic use
  • Stroke / drug therapy*
  • Stroke / genetics

Substances

  • 5-Lipoxygenase-Activating Proteins
  • ALOX5AP protein, human
  • Benzenesulfonates
  • Cardiovascular Agents
  • Carrier Proteins
  • Membrane Proteins
  • Nitrogen Oxides
  • disufenton sodium
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 4